400 likes | 613 Views
Regional Centers of Excellence Academic defense against bioterrorism. Great Lakes (Region V) RCE Illinois, Indiana, Michigan, Minnesota, Ohio & Wisconsin Director: Olaf Schneewind, University of Chicago. Argonne National Laboratory Battelle Memorial Institute IIT-Research Institute
E N D
Regional Centers of ExcellenceAcademic defense against bioterrorism
Great Lakes (Region V) RCEIllinois, Indiana, Michigan, Minnesota, Ohio & WisconsinDirector: Olaf Schneewind, University of Chicago Argonne National Laboratory Battelle Memorial Institute IIT-Research Institute Illinois Institute of Technology Illinois State University Loyola University Chicago Mayo Clinic Medical College of Wisconsin Michigan State University National Wildlife Health Center Northwestern University Ohio State University Purdue University University of Chicago University of Cincinnati University of Illinois University of Michigan University of Minnesota University of Notre Dame University of Toledo University of Wisconsin Wayne State University Wright State University
Disease Agents Plague Yersinia pestis Anthrax Bacillus anthracis Smallpox Variola major Hemorrhagic Fever Ebola or Marburg Virus Tularemia Francisella tularensis Botulism Clostridium botulinum BioterrorismWhat are the major threats?
RCE Products: At the Frontier of Biodefense • Vaccines: • Plague, Smallpox, Anthrax, Tularemia, Botulism, Ebola • Drugs: • Antibiotics, Antiinfectives, Disinfectants • Diagnostics
UofC’s Ricketts Laboratory at ANL • Scheduled for completion in 2008 • BSL-3 facility • 45,000 sqf • Located at Argonne National Laboratory
Smallpox • Causative agent Variola major • Clinical diagnosis • Also - Electron microscopy, antibody and DNA tests • Prevention: Vaccination • Therapy: Vaccination • Immunglobin, Cidofovir?
Adverse Effect of VaccinationAtopic dermatitis and immune suppression
Smallpox research goals • Improved, attenuated vaccine • Drugs with proven efficacy • Real time detection • Evolution of poxviruses
Plague • Causative agent: Yersinia pestis • Inhalational uptake or flea transmission • Clinical diagnosis (2-5 days) • Prevention: antimicrobials • Therapy: aminoglycoside
LcrV at the Tip of Type III Needles Mueller et al. Science (2005)
Yersinia pestis LcrVKey to Plague Vaccine and Immune Suppression Overheim et al. IAI (2005)
rV10 Protection against Pneumonic Plaguei.n. challenge with 2,750 MLD Y. pestis CO92 DeBord et al. submitted (2006)
B. anthracis Life style of a cheater
Anthrax as a weapon • Dissemination of infectious spores • Inhalational anthrax - lethal iwithin 48 hours • B. anthracis strains resistant to all antibiotics • Evasion of protective immunity?
Research goals for anthrax • Vaccine that protects against respiratory anthrax • Drugs that inhibit antibiotic-resistant anthrax • Detection of anthrax spores in real time • Intelligence on engineered anthrax strains
Botulism • Neurotoxin of Clostridium botulinum • Toxin uptake oral or respiratory • Clinical diagnosis - paralysis • Prevention - none • Therapy - none
Research goals for botulism • Vaccine development • Drugs that inactivate intracellular toxin • Real time detection